Table 2 External validation of ototoxicity signal in FDA adverse event reporting system database.

From: Detection of unknown ototoxic adverse drug reactions: an electronic healthcare record-based longitudinal nationwide cohort analysis

 

Proportional reporting ratio

Reporting odds ratio

Cimetidine

1.48 (0.74–2.96)

1.49 (0.64–2.94)

Hydroxyzine

1.40 (1.11–1.76)

1.40 (1.10–1.76)

Sucralfate

1.55 (1.04–2.32)

1.56 (1.00–2.32)

Back to article page